R Radhakrishnan

Papers

Total Citations

H-Index

About

R. Radhakrishnan has made pioneering contributions to the intersection of nuclear medicine and interventional oncology, with a focus on improving diagnostic accuracy in lymphoma management. Their key research areas include PET/CT-guided biopsy techniques, post-therapy response assessment in hematologic malignancies, and the development of automated biopsy systems. Their most cited work, "Post-therapy lesions in patients with non-Hodgkin’s lymphoma characterized by 18F-FDG PET/CT-guided biopsy using automated robotic biopsy arm" (2017, 13 citations), represents a significant methodological advancement. This study rigorously evaluated the positive predictive value of post-therapy FDG-PET/CT in non-Hodgkin's lymphoma patients and demonstrated the clinical utility of robotic-assisted biopsy for characterizing residual lesions. By systematically correlating PET/CT findings with histopathology, Radhakrishnan provided critical evidence for differentiating treatment-related changes from residual disease, directly impacting clinical decision-making. This work has been instrumental in refining response assessment protocols and reducing unnecessary interventions. Radhakrishnan’s research exemplifies the translation of advanced imaging technology into precise, minimally invasive diagnostic procedures, establishing them as a key figure in the evolution of image-guided oncology.